Literature DB >> 2935688

Influence of pre-incubation with one antibody on the binding of a second by human lymphocytes.

F Eichler-Reiss, P Reizenstein, G Mathé.   

Abstract

The reaction was studied of the J5-monoclonal antibody with the common acute leukemia antigen (CALLA) on non-malignant human tonsil lymphatic cells, which were double labelled also with antibodies against the B1 and HLA-DR antigens or the kappa and lambda light chains. There were few cells (mean 0-1.4%) which were positive with J5 but not B1. Other percentages of labelled cells depended on the order in which the antibodies were added. If the J5-antibody was added first, more B1 positive cells are found than if the B1 antibody is added first. Similarly, a significant (p less than 0.01-p less than 0.001) increase (3.3-18.8%) in the percentage of cells positive with J5 was found when the B1, kappa, and HLA-DR antibodies were added first, but not if antibody against lambda chains is added first. This difference was most pronounced and most significant for B1. This difference can be explained inter alia by steric differences between antibody conjugated and non-conjugated antigens followed by unmasking of other antigens. Double labelling is thus not equal to two single labellings.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2935688     DOI: 10.1007/bf02934915

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  9 in total

1.  Independent movement of IgD and IgM molecules on the surface of individual lymphocytes.

Authors:  W Knapp; R L Bolhuis; J Rádl; W Hijmans
Journal:  J Immunol       Date:  1973-10       Impact factor: 5.422

2.  The common acute lymphoid leukemia antigen on b cells of chronic lymphoid leukemia and non-Hodgkin's lymphoma.

Authors:  C Canon; C Augier; P Reizenstein; A Goutner; F de Vassal; G Mathé
Journal:  Biomed Pharmacother       Date:  1983       Impact factor: 6.529

3.  Difference between monoclonal antibodies against the common acute leukemia antigen from two different hybridomas.

Authors:  C Canon; F Eichler-Reiss; P Reizenstein; G Mathé
Journal:  Anticancer Res       Date:  1983 Nov-Dec       Impact factor: 2.480

4.  A monoclonal antibody to human acute lymphoblastic leukaemia antigen.

Authors:  J Ritz; J M Pesando; J Notis-McConarty; H Lazarus; S F Schlossman
Journal:  Nature       Date:  1980-02-07       Impact factor: 49.962

5.  VIL-A1, a monoclonal antibody reactive with common acute lymphatic leukemia cells.

Authors:  W Knapp; O Majdic; P Bettelheim; K Liszka
Journal:  Leuk Res       Date:  1982       Impact factor: 3.156

6.  A unique cell surface antigen identifying lymphoid malignancies of B cell origin.

Authors:  L M Nadler; J Ritz; R Hardy; J M Pesando; S F Schlossman; P Stashenko
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

7.  Anatomical distribution of call antigen expressing cells in normal lymphatic tissue and in lymphomas.

Authors:  G Hoffmann-Fezer; W Knapp; S Thierfelder
Journal:  Leuk Res       Date:  1982       Impact factor: 3.156

8.  Stages of B cell differentiation in human lymphoid tissue.

Authors:  A K Bhan; L M Nadler; P Stashenko; R T McCluskey; S F Schlossman
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

9.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.